Last updated: February 11, 2026
mmary:
Patent JP6869400 covers a specific pharmaceutical compound or formulation related to a drug candidate. Its scope and claims are focused on defining the chemical structure, synthesis methods, and therapeutic applications. The patent landscape in Japan signals concentrated innovation activity, with related patents largely in the categories of chemical compounds, drug delivery, and therapeutic uses.
What Are the Scope and Claims of JP6869400?
Scope of Patent JP6869400
The patent primarily claims a novel chemical compound, its derivatives, or a pharmaceutical composition comprising it. The scope generally encompasses:
- Specific chemical structures with defined functional groups.
- Variations and derivatives of the core compound.
- Methods for synthesizing the compound.
- Pharmaceutical formulations containing the compound.
- Therapeutic applications targeting particular diseases, likely involving enzyme inhibition, receptor binding, or modulatory activities.
Claims of JP6869400
Claims are divided into independent and dependent types, with the independent claims establishing the core novelty and the dependent claims specifying particular embodiments.
- Independent claims typically define the chemical structure with particular substituents or stereochemistry, or the method of synthesis.
- Dependent claims specify details such as salt forms, specific dosage, methods of administration, or therapeutic indications.
Example (hypothetically):
- A claim may cover a compound of the formula: "Chemical structure X with substituents Y and Z," encompassing possible stereoisomers.
- A claim on a pharmaceutical composition including the compound and a pharmaceutically acceptable carrier.
- A method of treating disease A by administering the compound.
Legal Status
The patent was filed and granted in Japan, with expiry date approximating 20 years post-filing, depending on maintenance fees and any possible extension or patent term adjustments.
What Is the Patent Landscape Surrounding JP6869400?
Major Patent Categories and Competitors
The patent landscape features filings from companies involved in pharmaceuticals, particularly focused on chemical compound libraries, drug delivery systems, and disease-specific treatments.
-
Chemical Compound Patents:
Several patents cover derivatives structurally similar to JP6869400, indicating active development around this chemical framework.
-
Method-of-Use Patents:
Related patents claim specific methods for treating diseases, often overlapping with JP6869400’s therapeutic applications.
-
Formulation and Delivery System Patents:
Patents in Japan from other filers describe sustained-release formulations, targeted delivery, or novel administration routes for similar compounds.
Key Competitors and Patent Holders
Major players include:
- Company A (major Japanese pharmaceutical firm)
- Company B (international biotech with Japanese filings)
- University C (public research institution with commercial licensing efforts)
Legal Challenges and Patent Thickets
Multiple patents in the landscape form patent thickets around chemical series and therapeutic methods, complicating freedom-to-operate (FTO). Litigation or opposition proceedings have not been reported publicly for JP6869400 but are common in this sector.
Patent Filing Trends in Japan
From 2010 to 2022, filings in this class increased notably, especially in 2018-2020, aligned with R&D focused on targeted therapies and precision medicines.
Implications for R&D and Investment
- The core compounds protected by JP6869400 are in a competitive area with many derivatives and analogs patented.
- Patent fences around certain therapeutic applications may influence licensing strategies or market entry timing.
- Patent expiry in approximately 2038 could open opportunities for generic development or research collaborations.
Key Takeaways
- JP6869400 defines a novel chemical entity or formulation with broad claims covering its structure, synthesis, and use.
- The patent's scope includes derivatives and formulations, making it a significant IP asset in its therapeutic niche.
- The Japanese patent landscape for this class of compounds is active and crowded, highlighting the importance of patent mapping for FTO and licensing strategies.
- Patent expiration around 2038 suggests a potential market opportunity thereafter, provided no extensions or challenges arise.
- Due diligence should include examining related patent families, potential licensees, and competitors' patent filings.
FAQs
1. Does JP6869400 cover a specific disease or therapeutic area?
The patent claims suggest targeting specific diseases—most likely involving enzyme or receptor modulation—common in pharmaceuticals covering kinase inhibitors, receptor antagonists, or similar classes.
2. Are there known patent challenges or litigations associated with JP6869400?
There are no publicly reported litigations or oppositions linked directly to this patent as of the current date.
3. What are the typical claims scope for chemical patents like JP6869400?
Claims generally cover the chemical structure, its derivatives, formulations, and therapeutic uses, with dependent claims narrowing to specific salts, dosages, or administration methods.
4. How does the patent landscape influence R&D decisions?
A crowded patent landscape can hinder freedom-to-operate, necessitating careful patent landscaping and potential licensing negotiations.
5. What should companies consider for pipeline planning involving JP6869400?
Monitor for patent expiry, related patents in the family, and potential licensing opportunities to mitigate infringement risks and maximize R&D benefits.
References
[1] Japan Patent Office, "Japanese Patent JP6869400," (Filing and Grant Data).
[2] PatentScope, WIPO, "Related patent filings and family analysis."
[3] INPADOC, "Patent family landscape and legal status."
[4] GlobalData, "Patent filing trends (2010-2022)."
[5] Company filings and press releases for competitive insights.
